BG Medicine, Inc.  

(Public, NASDAQ:BGMD)   Watch this stock  
Find more results for BGMD
0.995
+0.065 (6.99%)
Mar 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.92 - 1.05
52 week 0.27 - 2.08
Open 0.96
Vol / Avg. 1.83M/323,587.00
Mkt cap 31.77M
P/E     -
Div/yield     -
EPS -0.27
Shares 34.53M
Beta 1.35
Inst. own 36%
Mar 31, 2015
Q4 2014 BG Medicine Inc Earnings Release - 9:30AM EDT - Add to calendar
Mar 31, 2015
Q4 2014 BG Medicine Inc Earnings Call - 8:30AM EDT - Add to calendar
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -344.89% -389.12%
Operating margin -321.30% -352.91%
EBITD margin - -348.81%
Return on average assets -102.22% -128.89%
Return on average equity -338.65% -
Employees 23 -
CDP Score - -

Address

SUITE 210, 880 WINTER STREET
WALTHAM, MA 02451
United States - Map
+1-781-8901199 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

BG Medicine, Inc. is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders. The Company�s BGM Galectin-3 Test is its first United States Food and Drug Administration, or FDA, cleared and CE Marked diagnostic product, available as a blood test in the United States and the European Union. The Company�s BGM Galectin-3 Test was included in the 2013 American College of Cardiology Foundation and the American Heart Association (ACCF/AHA) Guideline for the Management of Heart Failure. The Company markets and sells BGM Galectin-3 Test kits to clinical laboratories, hospitals, and health care providers. BG Medicine N.V. is the Company�s subsidiary.

Officers and directors

Stephane Bancel MBA Chairman of the Board
Bio & Compensation  - Reuters
Paul R. Sohmer M.D. President, Chief Executive Officer, Director
Age: 65
Bio & Compensation  - Reuters
Stephen P. Hall Chief Financial Officer, Executive Vice President, Treasurer
Age: 63
Bio & Compensation  - Reuters
Aram Adourian Ph.D. Senior Vice President, Chief Scientific Officer
Age: 44
Bio & Compensation  - Reuters
Noubar B. Afeyan Independent Director
Age: 52
Bio & Compensation  - Reuters
Harrison M. Bains Jr. Independent Director
Age: 70
Bio & Compensation  - Reuters
Timothy Harris Ph.D. Independent Director
Age: 63
Bio & Compensation  - Reuters
Stelios B. Papadopoulos Ph.D. Independent Director
Age: 65
Bio & Compensation  - Reuters
Brian S. Posner Independent Director
Age: 52
Bio & Compensation  - Reuters